table of content
1 Introduction to Research & Analysis Reports
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Obesity Drugs (Anti-obesity Medication) Overall Market Size
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size: 2021 VS 2028
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales: 2017-2028
3 Company Landscape
3.1 Top Anti-Obesity Drugs (Anti-obesity Medication) Players in Global Market
3.2 Top Global Anti-Obesity Drugs (Anti-obesity Medication) Companies Ranked by Revenue
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Companies
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Companies
3.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-Obesity Drugs (Anti-obesity Medication) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Obesity Drugs (Anti-obesity Medication) Players in Global Market
3.8.1 List of Global Tier 1 Anti-Obesity Drugs (Anti-obesity Medication) Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Obesity Drugs (Anti-obesity Medication) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Markets, 2021 & 2028
4.1.2 Prescription Drugs
4.1.3 OTC Drugs
4.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
4.2.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2022
4.2.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2023-2028
4.2.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
4.3.1 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2022
4.3.2 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2023-2028
4.3.3 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
4.4 By Type - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2021 & 2028
5.1.2 Childhood (0-6)
5.1.3 Juvenile (7-17)
5.1.4 Youth (18-40)
5.1.5 Middle Aged (41-60)
5.1.6 Elderly (Above 60)
5.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
5.2.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2022
5.2.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2023-2028
5.2.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
5.3.1 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2022
5.3.2 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2023-2028
5.3.3 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
5.4 By Application - Global Anti-Obesity Drugs (Anti-obesity Medication) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2021 & 2028
6.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue & Forecasts
6.2.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2022
6.2.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2023-2028
6.2.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales & Forecasts
6.3.1 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2022
6.3.2 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2023-2028
6.3.3 By Region - Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.4.2 By Country - North America Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.4.3 US Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.4.4 Canada Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.4.5 Mexico Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.5.2 By Country - Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.5.3 Germany Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.4 France Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.5 U.K. Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.6 Italy Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.7 Russia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.8 Nordic Countries Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.5.9 Benelux Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.6.2 By Region - Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.6.3 China Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6.4 Japan Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6.5 South Korea Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6.6 Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.6.7 India Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.7.2 By Country - South America Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.7.3 Brazil Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.7.4 Argentina Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales, 2017-2028
6.8.3 Turkey Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.8.4 Israel Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.8.5 Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
6.8.6 UAE Anti-Obesity Drugs (Anti-obesity Medication) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Zafgan
7.1.1 Zafgan Corporate Summary
7.1.2 Zafgan Business Overview
7.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.1.5 Zafgan Key News
7.2 Vivus
7.2.1 Vivus Corporate Summary
7.2.2 Vivus Business Overview
7.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.2.5 Vivus Key News
7.3 Shionogi
7.3.1 Shionogi Corporate Summary
7.3.2 Shionogi Business Overview
7.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.3.5 Shionogi Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Rhythm Pharmaceuticals
7.5.1 Rhythm Pharmaceuticals Corporate Summary
7.5.2 Rhythm Pharmaceuticals Business Overview
7.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.5.5 Rhythm Pharmaceuticals Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Corporate Summary
7.7.2 Orexigen Therapeutics Business Overview
7.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.7.5 Orexigen Therapeutics Key News
7.8 Novo Nordisk
7.8.1 Novo Nordisk Corporate Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.8.5 Novo Nordisk Key News
7.9 Norgine
7.9.1 Norgine Corporate Summary
7.9.2 Norgine Business Overview
7.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.9.5 Norgine Key News
7.10 Nalpropion Pharmaceuticals Inc.
7.10.1 Nalpropion Pharmaceuticals Inc. Corporate Summary
7.10.2 Nalpropion Pharmaceuticals Inc. Business Overview
7.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.10.5 Nalpropion Pharmaceuticals Inc. Key News
7.11 Merck
7.11.1 Merck Corporate Summary
7.11.2 Merck Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.11.5 Merck Key News
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Corporate Summary
7.12.2 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.12.5 GlaxoSmithKline Key News
7.13 F.Hoffmann-La Roche
7.13.1 F.Hoffmann-La Roche Corporate Summary
7.13.2 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
7.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.13.5 F.Hoffmann-La Roche Key News
7.14 Eisai
7.14.1 Eisai Corporate Summary
7.14.2 Eisai Business Overview
7.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.14.5 Eisai Key News
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Corporate Summary
7.15.2 Boehringer Ingelheim Business Overview
7.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.15.5 Boehringer Ingelheim Key News
7.16 Bayer AG
7.16.1 Bayer AG Corporate Summary
7.16.2 Bayer AG Business Overview
7.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.16.5 Bayer AG Key News
7.17 AstraZeneca
7.17.1 AstraZeneca Corporate Summary
7.17.2 AstraZeneca Business Overview
7.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.17.5 AstraZeneca Key News
7.18 Arena Pharmaceuticals
7.18.1 Arena Pharmaceuticals Corporate Summary
7.18.2 Arena Pharmaceuticals Business Overview
7.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.18.5 Arena Pharmaceuticals Key News
7.19 Amylin
7.19.1 Amylin Corporate Summary
7.19.2 Amylin Business Overview
7.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.19.5 Amylin Key News
7.20 Alizyme
7.20.1 Alizyme Corporate Summary
7.20.2 Alizyme Business Overview
7.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Major Product Offerings
7.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales and Revenue in Global (2017-2022)
7.20.5 Alizyme Key News
8 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity, Analysis
8.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity, 2017-2028
8.2 Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Obesity Drugs (Anti-obesity Medication) Supply Chain Analysis
10.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Value Chain
10.2 Anti-Obesity Drugs (Anti-obesity Medication) Upstream Market
10.3 Anti-Obesity Drugs (Anti-obesity Medication) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
